Lygos and CJ Food & Nutrition Tech, biotechnology company and business unit of South Korean-based CJ CheilJedang, announced a collaboration to support large-scale manufacturing of amino and organic acid precursors for Lygos' SoltellusTM and sustainable materials.
CJ has over 60 years in the fermentation business with expertise in microbial fermentation and infrastructure to scale and optimize production processes. The partnership enables Lygos to utilize CJ’s state-of-the-art manufacturing capacity, and access existing technology and optimization tools from their newly formed precision fermentation CDMO (Contract Development & Manufacturing Organization) business. Lygos intends to execute additional plans for near and mid-term demand for product applications of Soltellus and Ecoteria, while CJ will provide critical technical and strategic optimization for process and production to support commercialization, as per business wire.
“CJ’s innovative approach enables efficient technology development, leverages robust production capabilities across the value chain, and is a strong complement to our current and future commercial product offerings,” said Eric Steen, CEO of Lygos. “This partnership augments our commercialization strategy of Collaborate to Accelerate by providing access to CJ’s technology and optimization capabilities for fermentation processes as well as the potential to collaborate on new products.”
“Lygos represents a standout partner for us that has developed technology and commercial plans that meet our objectives for future growth,” said Lance Choi, CEO of CJ FNT. “We believe their success combined with our technical capabilities will help accrue additional partnerships to our CDMO business.”
Ecoteria malonates provide benefits in perfumes, coatings, agriculture chemicals, medicines, and other speciality applications in terms of safety, sustainability, performance, and supply resilience.